AdJane
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$2.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AdJane is a clinical-stage vaccine platform company that provides a scalable vaccine technology to address pandemic preparedness, antimicrobial resistance, and global health challenges.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AdJane Comparables
Compare AdJane with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delonix Bioworks | 80% | |
| Abera Bioscience | 80% | |
| POP Biotechnologies, Inc. | 77% | |
AdJane Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 |
AdJane Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 1194% MoM.
AdJane Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AdJane's valuation, stock price, and market status.